![](/img/cover-not-exists.png)
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator
Herbert, K E, Morgan, S, Prince, H M, Westerman, D A, Wolf, M M, Carney, D A, Yuen, K, di Iulio, J, Seymour, J FVolume:
23
Year:
2008
Language:
english
Pages:
8
DOI:
10.1038/leu.2008.302
File:
PDF, 157 KB
english, 2008